| # | Drug | Count |
|---|---|---|
| 0 | VALPROIC ACID | 473 |
| 1 | OXALIPLATIN | 185 |
| 2 | FLUOROURACIL | 179 |
| 3 | FLUOROURACIL CREAM, 0.5% | 179 |
| 4 | LEVETIRACETAM | 171 |
| 5 | LEVETIRACETAM IN SODIUM CHLORIDE | 166 |
| 6 | LEVETIRACETAM INJECTION | 166 |
| 7 | LEVETIRACETAM ORAL | 166 |
| 8 | TOPIRAMATE | 157 |
| 9 | QUETIAPINE | 156 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGZILARGINASE-NBLN | 2 | 0.0645 |
| 1 | VALPROIC ACID | 473 | 0.0149 |
| 2 | CARGLUMIC ACID | 9 | 0.0120 |
| 3 | PROBENECID AND COLCHICINE | 1 | 0.0098 |
| 4 | FLUPHENAZINE DECANOATE | 4 | 0.0092 |
| 5 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 3 | 0.0087 |
| 6 | SODIUM PHENYLBUTYRATE | 3 | 0.0071 |
| 7 | STIRIPENTOL | 15 | 0.0066 |
| 8 | NIMODIPINE | 6 | 0.0053 |
| 9 | FOMEPIZOLE | 1 | 0.0053 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 570 |
| 1 | Mood Stabilizer [EPC] | 537 |
| 2 | Atypical Antipsychotic [EPC] | 368 |
| 3 | Benzodiazepine [EPC] | 311 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 285 |
| 5 | Platinum-based Drug [EPC] | 253 |
| 6 | Corticosteroid [EPC] | 151 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 63 |
| 8 | Proton Pump Inhibitor [EPC] | 62 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 61 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 9 | 0.0119 |
| 1 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 20 | 0.0026 |
| 2 | Anti-epileptic Agent [EPC] | 570 | 0.0026 |
| 3 | Carnitine Analog [EPC] | 9 | 0.0024 |
| 4 | Mood Stabilizer [EPC] | 537 | 0.0024 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 20 | 0.0023 |
| 6 | Benzodiazepine Antagonist [EPC] | 2 | 0.0023 |
| 7 | Adrenal Steroid Synthesis Inhibitor [EPC] | 2 | 0.0020 |
| 8 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 3 | 0.0020 |
| 9 | Typical Antipsychotic [EPC] | 46 | 0.0018 |